Ocata Therapeutics Inc news

   Watch this stock
Showing stories 1 - 10 of about 81   

Articles published

OCAT 4.23 -0.19 (-4.30%)
price chart
Is Ocata Therapeutics' Lackluster Debut A Buy Or Sell? (OCAT)
The gross proceeds to Ocata Therapeutics from this offering are expected to be $30.25 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Ocata Therapeutics. The warrants will be exercisable ...
Advanced Cell Technology Changes Name to Ocata Therapeutics
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc., (OTCBB: OCAT) today announced the change of its company name to Ocata Therapeutics, Inc., effective immediately. The change, which has been approved by the Company's ...
Related articles »  
Midday Watch: Rock Creek (RCPI), Ocata Therapeutics (OCAT), Juno (JUNO ...
Shares of Rock Creek Pharmaceuticals, Inc. (RCPI) were down more than 30% this morning following the company's announcement of $3.7 million registered direct offering of common stock and warrants.
Ocata Therapeutics to Ring the NASDAQ Stock Market Opening Bell on June 24, 2015  MarketWatch
Ocata Therapeutics Announces Pricing of $30 Million Offering of Common Stock ...  Yahoo Finance UK
Ocata Therapeutics To Trade On Nasdaq Global Market: Can The Bulls Finally ...
Third, with Ocata qualifying for listing under the market value standard rule by having a market value in excess of $75 million, the company has positioned itself to not only attract institutional interest, but to attract institutional investment as ...
Ocata Therapeutics Inc (OTCMKTS:OCAT) Is Rewarded With Two New Immune ...  Traders350
The Butterfly Effect: Advanced Cell Technology Becomes Ocata Therapeutics ...
It also becomes aware of the need for added technical, scientific and business expertise, as well as seeking out additional exposure to larger groups of individuals who can successfully provide financial support.
Latest Updates on Ocata Therapeutics Inc (OTCMKTS:OCAT)  Equities Focus (registration)
Related articles »  
Cowen Has Initiated Coverage on Ocata Therapeutics Inc (OTC:OCAT) Stock with ...
Cowen started coverage on shares of Ocata Therapeutics Inc (OTC:OCAT) in an analyst report revealed to investors on 7 October.
Ocata Therapeutics Research Coverage Started at Cowen and Company (OCAT)  WKRB News
Ocata Therapeutics Now Covered by Cowen and Company (OCAT)  The Legacy
Ocata Therapeutics Successfully Completes Dosing in Phase 1/2 RPE Studies
Ocata Therapeutics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of regenerative ophthalmology therapeutics.
Ocata Therapeutics Licenses Induced Pluripotent Stem Cell Technology from ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Ocata Therapeutics, Inc. (“Ocata” or “the Company”; NASDAQ: OCAT), a leader in the field of Regenerative Ophthalmology™, today announced that it has entered into a definitive agreement with Allele ...
Ocata Therapeutics (OCAT) Enters iPSC Licensing Agreement with Allele Biotech  StreetInsider.com
Ocata Therapeutics licenses induced pluripotent stem cell (iPSC) technology ...  European Pharmaceutical Review
Ocata Therapeutics Announces Positive Results Reported in a Late Breaking ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Ocata Therapeutics, Inc. (“Ocata” or “the Company”; NASDAQ: OCAT), a leader in the field of Regenerative Ophthalmology™, announced today that data will be presented in a Late Breaking Abstract at the ...
Data from four trials support the safety and tolerability of hESC-derived ...  European Pharmaceutical Review
Ocata Therapeutics Added to Russell 2000, 3000, Global and Microcap Indices
Ocata Therapeutics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of Regenerative Ophthalmology therapeutics.